XM does not provide services to residents of the United States of America.

U.S. STOCKS International Paper, U.S. Bancorp, Micron Technology



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-International Paper, U.S. Bancorp, Micron Technology</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment. .N


At 8:25 ET, Dow e-minis 1YMc1 were down 0.22% at 39,452. S&P 500 e-minis ESc1 were down 0.15% at 5,535, while Nasdaq 100 e-minis NQc1 were down 0.22% at 19,969.25.

The top two NYSE percentage gainers premarket .PRPG.NQ:
** Suzano SA <SUZ.N>, up 16.2%
** Proto Labs <PRLB.N>, up 10%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Levi Strauss <LEVI.N>, down 15.7%
** International Paper <IP.N>, down 12%
** Hims & Hers Health <HIMS.N>, down 10%

The top two Nasdaq percentage gainers premarket .PRPG.O:
** Assure Holdings <IONM.O>, up 183.1%
** NLS Pharmaceutics AG <NLSP.O>, up 86.2%

The top three Nasdaq percentage losers premarket .PRPL.O:
** BranchOut Food <BOF.O>, down 38.9%
** Tonix Pharmaceuticals Holding <TNXP.O>, down 31.6%
** Immutep <IMMP.O>, down 30.7%


** International Paper IP.N: down 12% premarket
BUZZ - Slumps after Brazil's Suzano ends buyout talk nL4N3IP0PD


** Levi Strauss LEVI.N: down 15.7% premarket
BUZZ - Misses Q2 revenue estimates, shares plunge nL4N3IP0Q6


** Micron Technology MU.O: down 5.6% premarket
BUZZ - Slips after muted Q4 revenue outlook nL4N3IP0QP


** U.S. Bancorp USB.N: down 1.3% premarket
BUZZ - Dips after JPM downgrades to "neutral" nL4N3IO1L1


** Recursion Pharmaceuticals RXRX.O: down 20.2% premarket
BUZZ - Slides on deep-discounted $200 mln stock offering nL1N3IP0B5


** Walgreens Boots Alliance WBA.O: down 15.6% premarket
BUZZ - Down on 2024 profit forecast cut, store closures nL4N3IP0XX


(Compiled by Rajarshi Roy and Anuja Bharat Mistry in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.